CamNTF is a scientific forum open to all scientists interested in research and development of new therapeutics in Cambridge and the local area, including scientists at the University, Addenbrooke’s Hospital, pharmaceutical companies, biotechs, CROs, and not-for-profit organisations.
Launched in 2015, CamNTF hosts early-evening meetings open to all scientists interested in research into new therapeutics. These rotate around different organisations located in the Cambridge biotech cluster. Each two-hour session will begin with short scientific presentations and will be followed by networking and snacks (5.30pm-8pm).
Registration is now open for the next event on 23rd February and will close on 16th February
Date: 23 February 2016
Location: MedImmune/AstraZeneca, Milstein Building, Granta Park, Cambridge, CB21 6GH
18.10 – Tagrisso – the story of the preclinical and clinical development
Dr. Susan Galbraith, Vice President, Head of Oncology iMed, AstraZeneca, Cambridge
Organoids and CRISPR/Cas for autologous cell therapy
Dr. Bon-Kyoung Koo, Group Leader, WT-MRC Cambridge Stem Cell Institute, University of Cambridge
Generation of novel EGFR C797S cellular models through CRISPR/Cas9-driven precise genome engineering for use in drug discovery
Dr. Daniel O’Neill, Senior Research Scientist, Discovery Sciences, AstraZeneca, Cambridge